CDC: Physicians Should Discuss Meds to Reduce HIV Risk
The CDC has recommended that
primary care physicians talk to all sexually active patients about prophylactic
medications that can lessen HIV transmission risk. Pre-exposure prophylaxis, or
PrEP, can be 99% effective in reducing risk.
Key Takeaways
The Centers for Disease Control
and Prevention (CDC) is now recommending that physicians discuss prophylactic
drugs that reduce the risk of HIV transmission (PrEP) with all of their
patients who are sexually active.
A brief discussion of a
patient’s sexual history should be part of primary care and should guide
physicians in discussing whether patients might need PrEP.
Many physicians skip taking a
sexual history of patients—either because of their own or their patients’
discomfort. As a result, patients who could benefit from PrEP miss out on key
HIV prevention measures.
verywellhealth.com
– CDC: All Sexually Active Patients Should Know About HIV Prevention Drugs
US CDC – Pre-Exposure
Prophylaxis (PrEP), Quick Guide: 2021 PrEP Update, Clinicians’ Quick Guide
< Previous Article |
Next Article >
[ return to top ]
|
In This Issue
